For treatment-naïve adults with HIV-1. See Full Indication.

INTERACTIVE QUIZ FOR DOVATO

Through this interactive experience, you'll delve a little deeper into the clinical trial data for DOVATO. Track your progress as you move from each chapter, and upon completion, you'll receive a congratulatory message and be able to review the correct answers.
Good luck!

CHAPTER 1:

GEMINI 1 & 2 TRIAL DESIGNS

CHAPTER 2:

48-WEEK PRIMARY ENDPOINT

CHAPTER 3:

96-WEEK EFFICACY & RESISTANCE

CHAPTER 4:

DRUG-RELATED ADVERSE EVENTS

CHAPTER 5:

RESULTS IN HIGH VIRAL LOADS

CHAPTER 6:

BONE/RENAL BIOMARKERS

DISCOVER A COMPLETE DTG-BASED 2-DRUG REGIMEN  

The estimated time to finish the whole learning experience is approximately 15 minutes.

DLLWCNT190030

Through this interactive experience, you'll delve a little deeper into the clinical trial data for DOVATO. Track your progress as you move from each chapter, and upon completion, you'll receive a congratulatory message and be able to review the correct answers.
Good luck!

CHAPTER 1:

GEMINI 1 & 2 TRIAL DESIGNS

CHAPTER 2:

48-WEEK PRIMARY ENDPOINT

CHAPTER 3:

96-WEEK EFFICACY & RESISTANCE

CHAPTER 4:

DRUG-RELATED ADVERSE EVENTS

CHAPTER 5:

RESULTS IN HIGH VIRAL LOADS

CHAPTER 6:

BONE/RENAL BIOMARKERS

DISCOVER A COMPLETE DTG-BASED 2-DRUG REGIMEN  

The estimated time to finish the whole learning experience is approximately 15 minutes.

DLLWCNT190030